Tag: medisafe

BOSTON, MA / ACCESSWIRE / February 28, 2023 / Medisafe, a leading digital health solutions company specializing in medication engagement, is pleased to announce the addition of several new executive team members to support the company’s strategy and goal of enabling a patient-centric approach to medication management. Read...

BOSTON, Jan. 4, 2023 /PRNewswire/ — Medisafe, a leading digital therapeutics company specializing in medication engagement, is pleased to announce its Software as a Medical Device (SaMD) technology. This announcement comes just months after achieving ISO 13485:2016 certification, meeting quality management system parameters specific to medical devices, as well as ISO 27001:2013 certification, meeting IT security management system standards specific to medication and digital health platforms. International registrations mark Medisafe’s continued leadership in the clinical management and patient engagement space. Read...

This will allow nurses and case managers to better monitor patients and intervene faster Read...

BOSTON, Oct. 25, 2022 /PRNewswire/ — A new survey of more than 2,000 patients by leading digital therapeutics company Medisafe shows receiving support for mental health conditions is the biggest challenge among nearly all patient segments. The survey aimed to collect data on what health concerns continue to dominate patients’ lives in a digitally engaged healthcare environment. Fifty one percent of patients cited mental health support as their primary need. Read...

BOSTON, Sept. 7, 2022 /PRNewswire/ — Medisafe, the leading medication engagement company, today announced that it has achieved the ISO 13485:2016 certification which supports the design and development of Software as a Medical Device (SaMD) used for the diagnosis, prognosis, or prediction of disease progression. Achieving this new certification serves as third-party industry validation that Medisafe continues to enhance its offering in support of pharma’s vision for a more integrated and digitally enhanced future. Read...